Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Behrens

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Zeitschrift Fur Rheumatologie|August 11, 2021
[Development of quality standards for patients with axial spondyloarthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Zeitschrift Fur Rheumatologie|June 8, 2017
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]F Proft, H Schulze-Koops, M Grunke, et al.
Zeitschrift Fur Rheumatologie|July 4, 2018
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]C Fiehn, J Holle, C Iking-Konert, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Zeitschrift Fur Rheumatologie|August 11, 2021
[Development of quality standards for patients with axial spondyloarthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Zeitschrift Fur Rheumatologie|June 8, 2017
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]F Proft, H Schulze-Koops, M Grunke, et al.
Zeitschrift Fur Rheumatologie|July 4, 2018
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]C Fiehn, J Holle, C Iking-Konert, et al.
Pageof 16